2-Hydroxybenzylamine (2-HOBA) Study in Early Alzheimer's Patients
2-Hydroxybenzylamine (2-HOBA) Study in Early Alzheimer's Patients
Not yet recruiting · NCT06432166 · Registry updated 2026-09-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| 2-Hydroxybenzylamine (2-HOBA) Study in Early Alzheimer's Patients | Alzheimer disease, Cognition Disorders, Cognitive Dysfunction, Mild Cognitive Impairment, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Not yet recruiting | Phase 1 / Phase 2 | 2026-09-24 | NCT06432166 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| MTI Biotech Inc | 1 |
| Vanderbilt University Medical Center | 299 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Center for Cognitive Medicine, Vanderbilt University Medical Center | Nashville | United States | 1 |